European Union reserves 400 million doses of possible anti vaccine - CO VID19

The European Commission announced today that it has reserved as many as 400 million doses of possible vaccines on behalf of EU member states COVID-19, developed by American company “Johnson & Johnson”. “Exploratory talks between the Commission and “Johnson & Johnson” aim to make a framework available for a first purchase of 200 [...]
“Exploration talks between the Commission and “Johnson & Johnson” aim to make a framework available for a first 200 million dose purchase, which can be followed by a second purchase for a similar number of derzas”, correctly The EC in a press release.
The EC and the American company are still expected to hold negotiations on the envisioned contract.












